Michael Shuster provides strategic intellectual property legal services to biotechnology and chemical/pharmaceutical companies. His practice includes patent prosecution, portfolio analysis, due diligence, litigation and opinion work. His clients include start-up and established biotechnology companies, venture capital firms and research universities and hospitals.
Michael has legal and technical experience in protein and nucleic acid chemistry, clean tech, high resolution protein structures, proteomics, genomics, combinatorial peptide libraries, vaccine development for viral and autoimmune disorders, transdermal drug delivery systems, liposomal drug formulations and microfluidics devices.
Before becoming an attorney, Michael’s career experience included graduate research in the laboratory of Professor Eric Kandel at Columbia University as part of a team focused on discovery of mechanisms by which short-term memories are stored, research for which Professor Kandel was awarded the 2000 Nobel Prize in Medicine. Michael then moved to the Department of Biochemistry and Biophysics at the University of California, San Francisco, where he pursued his interests in ion channel biophysics and protein structure.
Currently, Michael is a co-instructor of "A Life Scientist's Guide to Intellectual Property" at UCSF, and regularly lectures about intellectual property law subjects. He is past chair of the Intellectual Property section of the Barrister's Club of San Francisco. Michael was named one of Top 25 Biotech Lawyers in California in 2011 and one of the Top 25 Intellectual Property Portfolio Managers in 2009 and 2012 by the Daily Journal. He was also recognized as a "Life Sciences Star" for his outstanding patent work in Euromoney's LMG Life Sciences 2012 and 2013, as a Northern California “Super Lawyer” in 2013 and 2014, as well as an IP Star by Managing Intellectual Property.
Michael has published numerous scientific papers in peer-reviewed journals as well as articles on biotechnology patent law. Representative technologies for which he's written and prosecuted patent applications include genomics, proteomics, bioinformatics, vaccines, microfluidic devices, drug delivery methods and microarrays.
Organization and Community Participation
- American Bar Association
- California Bar Association
- San Francisco Bar Association
- San Francisco Intellectual Property Law Association
- Biophysical Society
- Justices Consider Patent Process for Personalized Medicine Industry, Michael Shuster, Daily Journal, February 15, 2012
- A Comparison of US and EU Biosimilars Regimes, Michael Shuster & Pauline Farmer-Koppenol, January 6, 2012.
- Classen v. Biogen Idec et al. – The Latest Installment in the Patent-Eligibility Arena, Pauline Farmer-Koppenol & Michael Shuster, October 6, 2011
- Silicon Valley News Radio Interview (Podcast), Michael Shuster, KLIV, October 5, 2011
- Patenting Personalized Medicine Inventions after Myriad, Pauline Farmer-Koppenol & Michael Shuster, August 29, 2011
- First to File in the Unpredictable Arts: Change in Law Requires Balancing of Competing Interests, Nicholas Hurt & Michael Shuster, Daily Journal, August 5, 2011
- Getting the Prescription Right for Patenting Personalized Medicine Innovations, Michael Shuster & Pauline Farmer-Koppenol, iPFrontline Magazine, May 2011
- Biotech in the Wake of 'Bilski', Michael Shuster & Pauline Farmer-Koppenol, The Recorder, July 2010
- Patent Strategy for Personalized Medicine in Light of Bilski, Michael Shuster & Pauline Farmer-Koppenol, July 2010
- Of Babies and Bathwater The Impact of In Re Bilski on Life Science Patents, Michael Shuster & Juleen Konkel, 1 Hastings Science and Technology Law Journal 153, Summer 2009
- An Unclear Diagnosis, Michael Shuster & Juleen Konkel Daily Journal, June 2009
- Protecting Patents for Personalized Medicine, Michael Shuster & Pauline Farmer-Koppenol BioPharm International, September 2008
- Observations on Recent Developments in Patent Law: Is the Generic Claim Turning Into an Endangered Species?, Michael J. Shuster, Pauline Farmer-Koppenol & H. Thomas Anderson Jr. Burrill Report Personalized Medicine, November, 2007
- Planning for the other shoe to drop - Future echoes of LabCorp v. Metabolite, Michael J. Shuster & H. Thomas Anderson Jr. Burrill Report Personalized Medicine, November, 2006
- Responding to the Avian Flu Threat: Balancing Risks and Rewards, Michael J. Shuster, BioPharm International, February 1, 2006
- Managing Innovation: University-industry partnerships and the licensing of the Harvard mouse, Sasha Blaug, Colleen Chien & Michael J. Shuster Nature Biotechnology, Vol. 22, No. 6 (June 2004)
- Altering Patent Suit Proof Burden Would Chill Innovation, Michael J. Shuster, Daniel Flamm & Sasha Blaug, Washington Legal Foundation, April 16, 2004
- Enzo Biochem v. Gen-Probe: Complying with the written description requirement under U.S. patent law, Nature Biotechnology, January, 2003
- Protecting Rights to Early-Stage Technology, Michael J. Shuster, Henry Su & Sasha Blaug, Nature Biotechnology, June, 2003
- Supreme Court View on Prometheus Case, Personalized Medicine World Conference (PMWC), January 23, 2012
- Consumer Protection or Government Intrusion: Is Regulation appropriate? Is it different in Europe? Japan? Are companies moving away from “betting the company” on the FDA?, Burrill Personalized Medicine Conference, October 4, 2011
- AMA Speaker Series - Life Sciences, Asia America MultiTechnology Association, June 26, 2007
- Life Science Entrepreneurs' Forum, FountainBlue Consulting Services, September 18, 2006
- A Life Scientist's Guide to Intellectual Property: Drafting Patent Applications, UCSF, April 25, 2006
- A Life Scientist'' Guide to Intellectual Property: Life and Death of a Patent, UCSF, April 18, 2006
- 6th Advanced Forum on Biotech Patents: Constructing The Plan For The Future, American Conference Institute, February 16, 2006
- Radio Interview on World Talk Radio's Biotech Today, September 24, 2003